The efficacy of eszopiclone (Lunesta) for Chronic insomnia associated with osteoarthritis

Trial Profile

The efficacy of eszopiclone (Lunesta) for Chronic insomnia associated with osteoarthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Nov 2017

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Insomnia; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 07 Jun 2013 Planned end date changed from 1 Jan 2008 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 23 Oct 2006 The expected completion date for this trial is now 1 Jan 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top